Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Macrophage TIPE2 Loss Drives ASC Ferroptosis in Obesity
2026-06-30
This study uncovers how obesity-associated macrophages, via loss of TIPE2, induce ferroptosis in adipose stem cells (ASCs), thereby destabilizing visceral fat homeostasis. The findings shed light on the mechanistic crosstalk between immune cells and ASC fate, revealing targets for future metabolic disease interventions.
-
miR-18a Drives Glioblastoma via ALOXE3 Suppression and Ferro
2026-06-30
This study reveals that miR-18a facilitates glioblastoma (GBM) progression by downregulating ALOXE3, thereby impairing ferroptotic cell death and enhancing tumor cell migration. The findings identify the miR-18a/ALOXE3 axis as a mechanistically distinct regulator of lipid metabolism and ferroptosis in GBM, with implications for targeting metabolic vulnerabilities in aggressive brain tumors.
-
SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin
2026-06-29
This study identifies SEMA3E as a key regulator of beige adipocyte differentiation and thermogenesis in mice, acting through modulation of β-catenin signaling. The findings elucidate novel molecular mechanisms relevant to metabolic regulation and provide a valuable model for investigating adipose tissue plasticity.
-
ISRIB (trans-isomer): PERK Inhibitor Workflows for Memory &
2026-06-29
ISRIB (trans-isomer) stands out as a potent PERK inhibitor, enabling precise modulation of the integrated stress response in both cognitive and ER stress research. Its proven ability to cross the blood-brain barrier and reverse maladaptive forgetting uniquely positions it for advanced neurodegenerative disease and apoptosis models.
-
miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G
2026-06-28
This study reveals that miR-18a promotes glioblastoma progression by targeting and downregulating ALOXE3, thereby impairing ferroptotic cell death and enhancing tumor cell migration. The findings illuminate new regulatory links between lipid metabolism, ferroptosis, and GBM aggressiveness, offering mechanistic insights that may inform the development of targeted cancer therapies.
-
Nutlin-3a MDM2 Inhibitor: Optimizing p53 Pathway Activation
2026-06-27
Nutlin-3a is a gold-standard MDM2 inhibitor enabling precise p53 pathway activation, robust cell cycle arrest, and apoptosis induction in cancer research. This guide translates recent mechanistic insights and protocol refinements into actionable workflows, troubleshooting tips, and next-generation assay strategies.
-
Nutlin-3a: Precision MDM2 Inhibitor Optimizing Cancer Resear
2026-06-26
Nutlin-3a empowers researchers to activate the p53 pathway and induce apoptosis with accuracy across cancer models, offering robust data and reproducibility advantages. This guide provides actionable workflow enhancements and troubleshooting insights for advanced applications, including glioblastoma and lymphoma research.
-
Reliable mRNA Synthesis with HyperScribe™ All in One (SKU K1
2026-06-26
This article explores how the HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, ψUTP, T7, poly(A)), SKU K1064, addresses key laboratory pain points in mRNA synthesis for translational research. By grounding recommendations in peer-reviewed evidence and real-world workflow scenarios, we demonstrate the kit's reproducibility, efficiency, and usability advantages for RNA vaccine development, in vitro translation, and related applications.
-
G418 Sulfate (Geneticin): Precision Selection & Antiviral Po
2026-06-25
G418 Sulfate (Geneticin) stands out as a dual-purpose powerhouse, enabling both robust genetic engineering selection and antiviral research workflows. Its unique efficacy—rooted in targeted ribosomal inhibition—delivers reproducible results for stable cell line development and emerging viral inhibition assays.
-
Liproxstatin-1 HCl: Reframing Ferroptosis Research for Trans
2026-06-25
This article explores the strategic integration of mechanistic discoveries in ferroptosis—especially mitochondrial calcium signaling and GPX4 acetylation—with translational research workflows. We highlight Liproxstatin-1 HCl as an advanced tool for dissecting regulated cell death, drawing on recent evidence and providing actionable protocol guidance for acute organ injury models.
-
Novobiocin Sodium: Advanced Applications in DNA Replication
2026-06-24
Novobiocin Sodium, an aminocoumarin antibiotic, is revolutionizing bacterial DNA replication and cell morphogenesis studies with its precise inhibition of DNA gyrase. This article unpacks experimental workflows, troubleshooting guidance, and actionable protocol parameters that maximize the utility of Novobiocin Sodium in metabolic enzyme and apoptosis pathway research.
-
Geneticin (G418 Sulfate): Redefining Selection and Antiviral
2026-06-23
Explore the mechanistic foundations and translational impact of Geneticin (G-418 Sulfate), an aminoglycoside antibiotic central to genetic engineering and antiviral research. This article frames current challenges in cell line development and virus inhibition, integrates insights from recent mechanistic studies, and offers strategic guidance for leveraging APExBIO's ultra-pure Geneticin in advanced translational workflows.
-
WIP1/PPM1D Inhibition Drives Pyroptosis via p38 MAPK in AKI
2026-06-23
This study uncovers how pharmacological inhibition of WIP1/PPM1D augments renal tubular pyroptosis during sepsis-associated acute kidney injury (AKI) through enhanced p38 MAPK activation. The findings illuminate a critical regulatory axis in inflammatory kidney injury and provide a mechanistic basis for using PPM1D inhibitors to dissect pyroptosis in translational research.
-
SB743921: Precision Kinesin Spindle Protein Inhibitor Workfl
2026-06-22
SB743921, a highly selective kinesin spindle protein inhibitor, enables robust cell cycle arrest and apoptosis studies in diverse cancer models. This article demystifies hands-on workflows, troubleshooting strategies, and the latest in vitro assay innovations that maximize reproducibility and data quality with SB743921.
-
Human iPSC Sensory Neuron Model Validated for HSV-1 Latency
2026-06-22
This study establishes and validates a robust protocol for differentiating human inducible pluripotent stem cells into sensory neurons, enabling reproducible modeling of herpes simplex virus 1 (HSV-1) latency and reactivation in vitro. The findings provide a scalable human-based system to dissect neuron-intrinsic mechanisms of HSV-1 persistence and inform future therapeutic strategies against latent herpesvirus infection.